Literature DB >> 11124154

Acute hypertension inhibits thirst stimulated by ANG II, hyperosmolality, or hypovolemia in rats.

S D Stocker1, E M Stricker, A F Sved.   

Abstract

The present study sought to determine whether increases in arterial blood pressure inhibited drinking behavior evoked by ANG II, hyperosmolality, or hypovolemia in rats. Cumulative water intakes in 60- or 90-min tests and latency to the first lick were recorded as indexes of thirst. During intravenous infusions of 100 ng. kg(-1). min(-1) ANG II, attenuation of the induced increases in arterial pressure with the arteriolar vasodilator diazoxide resulted in greater water intakes and shorter latencies to drink. Drinking behavior stimulated by intravenous infusion of hypertonic saline was significantly inhibited by increases in arterial pressure caused by intravenous infusion of phenylephrine or endothelin-1, and this inhibition of drinking was proportional to the induced increase in pressure. Upon termination of the phenylephrine infusion, mean arterial pressure returned to basal values, and drinking was restored. Phenylephrine-induced increases in arterial pressure also inhibited drinking behavior in response to hypovolemia that could not be explained by differences in plasma renin activity, plasma protein concentration, or plasma osmolality. Thus increases in arterial pressure inhibit water drinking behavior in response to each of these three thirst stimuli in rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124154     DOI: 10.1152/ajpregu.2001.280.1.R214

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  10 in total

1.  Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.

Authors:  Janice C Froehlich; Brett J Hausauer; Dennis D Rasmussen
Journal:  Alcohol Clin Exp Res       Date:  2013-07-22       Impact factor: 3.455

2.  Median preoptic neurones projecting to the hypothalamic paraventricular nucleus respond to osmotic, circulating Ang II and baroreceptor input in the rat.

Authors:  Sean D Stocker; Glenn M Toney
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

3.  Differential activation of adrenal, renal, and lumbar sympathetic nerves following stimulation of the rostral ventrolateral medulla of the rat.

Authors:  Patrick J Mueller; Nicholas A Mischel; Tadeusz J Scislo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-23       Impact factor: 3.619

Review 4.  2015 Distinguished career award: Reflections on a career in science.

Authors:  Edward M Stricker
Journal:  Physiol Behav       Date:  2015-10-03

Review 5.  The neural basis of homeostatic and anticipatory thirst.

Authors:  Claire Gizowski; Charles W Bourque
Journal:  Nat Rev Nephrol       Date:  2017-11-13       Impact factor: 28.314

Review 6.  Estradiol and osmolality: Behavioral responses and central pathways.

Authors:  Kathleen S Curtis
Journal:  Physiol Behav       Date:  2015-06-12

7.  Central TrkB blockade attenuates ICV angiotensin II-hypertension and sympathetic nerve activity in male Sprague-Dawley rats.

Authors:  Bryan K Becker; Hanjun Wang; Irving H Zucker
Journal:  Auton Neurosci       Date:  2017-05-19       Impact factor: 3.145

8.  Estradiol selectively reduces central neural activation induced by hypertonic NaCl infusion in ovariectomized rats.

Authors:  Alexis B Jones; Eryn E Bass; Liming Fan; Kathleen S Curtis
Journal:  Physiol Behav       Date:  2012-07-02

9.  Vagal afferent input alters the discharge of osmotic and ANG II-responsive median preoptic neurons projecting to the hypothalamic paraventricular nucleus.

Authors:  Sean D Stocker; Glenn M Toney
Journal:  Brain Res       Date:  2006-12-11       Impact factor: 3.252

10.  Activation of neuronal endothelin B receptors mediates pressor response through alpha-1 adrenergic receptors.

Authors:  Bryan K Becker; Joshua S Speed; Mackenzie Powell; David M Pollock
Journal:  Physiol Rep       Date:  2017-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.